Actinogen Medical Limited

ASX:ACW Rapporto sulle azioni

Cap. di mercato: AU$65.1m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Actinogen Medical Gestione

Gestione criteri di controllo 3/4

Actinogen Medical's Il CEO è Steve Gourlay, nominato in Mar2021, e ha un mandato di 3.42 anni. la retribuzione annua totale è A$ 656.89K, composta da 60.2% di stipendio e 39.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 3.56% delle azioni della società, per un valore di A$ 2.41M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.5 anni e 6.7 anni.

Informazioni chiave

Steve Gourlay

Amministratore delegato

AU$656.9k

Compenso totale

Percentuale dello stipendio del CEO60.2%
Mandato del CEO3.4yrs
Proprietà del CEO3.6%
Durata media del management2.5yrs
Durata media del Consiglio di amministrazione6.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Apr 30
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Nov 16
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Aug 02
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

Apr 12
We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Nov 28
We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Aug 09
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Apr 07
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Oct 24
We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

Jul 11
Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

Mar 27
We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Jan 07
How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Steve Gourlay rispetto agli utili di Actinogen Medical?
DataCompenso totaleStipendioGuadagni aziendali
Dec 31 2023n/an/a

-AU$15m

Sep 30 2023n/an/a

-AU$13m

Jun 30 2023AU$657kAU$396k

-AU$11m

Mar 31 2023n/an/a

-AU$11m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$10m

Jun 30 2022AU$955kAU$376k

-AU$9m

Mar 31 2022n/an/a

-AU$8m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$6m

Jun 30 2021AU$271kAU$112k

-AU$4m

Compensazione vs Mercato: La retribuzione totale di Steve ($USD 442.89K ) è superiore alla media delle aziende di dimensioni simili nel mercato Australian ($USD 300.79K ).

Compensazione vs guadagni: La retribuzione di Steve è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Steve Gourlay (64 yo)

3.4yrs

Mandato

AU$656,888

Compensazione

Dr. Steven G. Gourlay, also known as Steve, MBBS (M.D.), Ph D., FRACP, M.B.A., serves as Chief Executive Officer at Actinogen Medical Limited since March 15, 2021 and as its Managing Director and Director...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Steven Gourlay
MD, CEO & Director3.4yrsAU$656.89k3.56%
A$ 2.3m
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board1.5yrsAU$478.29kNessun dato
Paul Rolan
Head of Clinical Pharmacology & Lead Physician and Depression2.5yrsAU$191.66kNessun dato
William Souter
Chief Financial Officerless than a yearNessun datoNessun dato
Michael Roberts
Head of Investor Relations & Corporate Communications3.3yrsNessun datoNessun dato
Fujun Li
Head of Manufacturingless than a yearNessun datoNessun dato
Peter Webse
Company Secretary10.8yrsNessun datoNessun dato

2.5yrs

Durata media

64yo

Età media

Gestione esperta: Il team dirigenziale di ACW è considerato esperto (durata media dell'incarico 2.5 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Steven Gourlay
MD, CEO & Director3.4yrsAU$656.89k3.56%
A$ 2.3m
Dana Hilt
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board2.6yrsAU$478.29kNessun dato
George Morstyn
Independent Non-Executive Director6.7yrsAU$118.33k0.44%
A$ 287.4k
Geoffrey Edward Brooke
Independent Non-Executive Chairman7.4yrsAU$241.61k0.70%
A$ 452.5k
Colin Masters
Member of Xanamem Clinical Advisory Board9.4yrsNessun datoNessun dato
Jeffrey Cummings
Member of Xanamem Clinical Advisory Board9.4yrsNessun datoNessun dato
Malcolm McComas
Independent Non-Executive Director5.3yrsAU$118.33k0.26%
A$ 172.1k
John Harrison
Member of Depression & Cognition Clinical Advisory Board2.6yrsNessun datoNessun dato
Craig Ritchie
Chairman of Xanamem Clinical Advisory Board9.4yrsNessun datoNessun dato
Jonathan Seckl
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Brian Walker
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Scott Webster
Member of Scientific Advisory Boardno dataNessun datoNessun dato

6.7yrs

Durata media

71yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ACW sono considerati esperti (durata media dell'incarico 6.7 anni).